Alpha-fetoprotein with AFP-L3%

Alphabetical Test listing

Alpha-fetoprotein with AFP-L3%-994

  
Alpha-fetoprotein with AFP-L3%
  
994
  
LAB994
  
MSO
  
α-Fetoprotein
AFP
  

The AFP-L3% assay is intended for use in the assessment of risk for the development of hepatocellular carcinoma (HCC) in patients with chronic liver diseases.

Values obtained with different assay methods should not be used interchangeably in serial testing. It is recommended that only one assay method be used consistently to monitor each patient's course of therapy.

  
Serum
  
  
0.5 mL
  
0.3 mL
Note: this volume does not allow for repeat testing
  

Spin

  

Gold serum separator (SST) tube

  
  
0.5 mL
  

Spin and separate

  
  

Refrigerated (preferred) - 9 days

Frozen - 9 days

Ambient - 9 days

  
  • Gross icterus
  
LabCorp Burlington (141300): R-NX
  
Mo - Fr
  
1 - 3 days
  

Liquid-phase Binding assay

  

AFP Serum: 0.0 - 8.0 ng/dL
AFP L3%:    0.0 - 9.9 %

  
82107
  
Result 42332-7
  
06/03/2019
  
10/26/2020